Low Weight Gain Over 96 Wks in Treatment-Naive Patients Initiating ART With Doravirine

IDWeek 2019; October 2-6, 2019; Washington, DC
21st International Workshop on Co-morbidities and Adverse Drug Reactions in HIV; November 5-6, 2019; Basel, Switzerland
17th European AIDS Conference; November 6-9, 2019; Basel, Switzerland
In patients receiving first-line doravirine, median weight gain over 96 weeks was 1.5 kg, a change similar to that seen in adults without HIV infection and in those starting ART with other agents.
Format: Microsoft PowerPoint (.ppt)
File Size: 204 KB
Released: November 18, 2019

Acknowledgements

Provided by USF Health

USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602

(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)
cpdsupport@health.usf.edu
http://www.cme.hsc.usf.edu

Supported by educational grants from
Gilead Sciences
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

Audio from CCO faculty, Drs. John Faragon and Paul Sax, on avoiding drug interactions between ART and acid reducers, rifampin, or corticosteroids in patients with HIV

John Faragon, PharmD, BCPS, AAHIVP Paul E. Sax, MD Released: February 13, 2020

CCO audio from Drs. Kenneth Mayer and W. David Hardy on new treatment and prevention strategies for patients with or at risk of HIV

W. David Hardy, MD Kenneth Mayer, MD Released: February 13, 2020

CCO audio from Drs. Anne-Geneviève Marcelin and Jürgen Rockstroh on new treatment and prevention strategies for patients with or at risk of HIV

Anne-Geneviève Marcelin, PharmD, PhD Jürgen K. Rockstroh, MD Released: February 13, 2020

Audio from CCO faculty, Drs. David Back and Marta Boffito, on avoiding drug interactions between ART and acid reducers, rifampicin, or corticosteroids in patients with HIV

David J. Back, PhD, FRCP Marta Boffito, MD, PhD, FRCP Released: February 13, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?